# Arkansas Expanded Access COVID-19 Convalescent Plasma Treatment Program

> **NCT04363034** · — · NO_LONGER_AVAILABLE · sponsor: **University of Arkansas**

## Conditions studied

- COVID-19

## Interventions

- **BIOLOGICAL:** Convalescent Plasma

## Key facts

- **NCT ID:** NCT04363034
- **Lead sponsor:** University of Arkansas
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** NO_LONGER_AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2023-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04363034

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04363034, "Arkansas Expanded Access COVID-19 Convalescent Plasma Treatment Program". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04363034. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*